2020 Cochrane Review showed that in symptomatic patients, transfemoral CAS was associated with higher risk
of periprocedural death or stroke than CEA, (OR, 1.70;
95% CI, 1.31-2.19; P < .0001, I2 Â¼ 5%; 10 trials; 5396 participants; high certainty evidence).202
Long-term outcomes